6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: June 28, 2024
Period of Report: June 28, 2024
Accession Number: 0001213900-24-056877

View Document ↗ View on SEC.gov ↗